Human IgG antibody Laboratories manufactures the antibody sars spike reagents distributed by Genprice. The Antibody Sars Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Sars Group: Spike
SARS Spike Antibody |
SAB |
100ul |
EUR 479 |
SARS Spike Antibody |
SAB |
100ul |
EUR 468 |
SARS Spike Antibody |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
SARS Spike Antibody |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
SARS Spike Antibody |
Abbexa |
100 tests |
EUR 362.5 |
Spike information
SARS Spike Antibody |
MBS9403751-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
SARS Spike Antibody |
MBS9404782-01mL |
MyBiosource |
0.1mL |
EUR 495 |
SARS Spike Antibody |
MBS9404782-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
SARS Spike Antibody |
MBS9407060-01mL |
MyBiosource |
0.1mL |
EUR 495 |
SARS Spike Antibody |
MBS9407060-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
SARS Spike Antibody |
MBS9413028-01mL |
MyBiosource |
0.1mL |
EUR 495 |
SARS Spike Antibody |
MBS9413028-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
SARS Spike Antibody |
MBS9413483-01mL |
MyBiosource |
0.1mL |
EUR 495 |
SARS Spike Antibody |
MBS9413483-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
SARS Antibody (CoV) (Spike) |
GWB-31A5B4 |
GenWay Biotech |
0.1 mg |
Ask for price |
|
SARS Antibody (CoV Spike) |
GWB-7E7002 |
GenWay Biotech |
0.1 mg |
Ask for price |
SARS MERS Spike Antibody |
abx137750-100tests |
Abbexa |
100 tests |
EUR 225 |
SARS-CoV Spike Antibody |
3219-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3219-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3221-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3221-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3223-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |